OrganJet Corporation is a company.
Key people at OrganJet Corporation.
OrganJet Corporation was founded by Sridhar Tayur (Founder).
OrganJet Corporation was founded by Sridhar Tayur (Founder).
OrganJet Corporation is a social enterprise founded in 2011 that provides advisory and transportation services to kidney and liver transplant patients, enabling them to multiple list at transplant centers nationwide and access organs faster via affordable private jet or other transport.[1][2][3] It serves patients facing geographic disparities in organ wait times, solving the problem of unequal access to deceased donor kidneys and livers by facilitating matches across U.S. Donor Service Areas (DSAs) and UNOS regions, often years ahead of local waits.[1][4][6] Key offerings include the Patient Information Service (PIS) for guidance on multiple listing and a free app for finding low-wait centers, with demonstrated success like a 2013 case where a patient received a kidney transplant years faster.[1][3][5]
OrganJet was founded in 2011 by Sridhar R. Tayur, a Carnegie Mellon University professor of operations management, Ford Distinguished Research Chair, and serial entrepreneur with no prior healthcare training.[1][2] Tayur, known for founding SmartOps (acquired by SAP in 2013), applied his expertise in supply chain optimization and matching supply-demand to tackle organ transplant inefficiencies, inspired by geographic disparities highlighted by cases like Steve Jobs's 2009 liver transplant.[2][4] Early traction included media coverage, attention from Nobel Laureate Alvin E. Roth, a 2013 successful kidney transplant for a D.C.-area patient via Pittsburgh, and a 2014 USA Today campaign to boost organ donation awareness.[1]
OrganJet rides the trend of operational tech innovations in healthcare supply chains, applying optimization algorithms and marketplaces to scarce resources like organs amid persistent geographic inequities in the U.S. transplant system.[2][4][6] Timing aligns with post-1998 DHHS rules exposing DSA disparities (e.g., waits varying from months to years), enabling "consumerist" solutions like multiple listing without reforming UNOS structures.[4] Market forces favoring it include rising private aviation access, software for real-time matching, and demand for equitable allocation amid organ shortages—influencing the ecosystem by spotlighting inefficiencies, inspiring policy debates, and demonstrating academic-to-real-world tech transfers.[1][5]
OrganJet's blend of advisory tech and logistics positions it to scale with AI-driven matching and expanded partnerships, potentially integrating telehealth or predictive wait analytics amid ongoing organ shortages.[5][6] Trends like regulatory pushes for equity (e.g., post-IOM recommendations) and drone/electric aviation could lower costs further, amplifying impact.[4] Its influence may evolve from niche facilitator to catalyst for systemic reform, helping more patients bypass waits—echoing Tayur's mission to transplant as many lives quicker.[1][2]
Key people at OrganJet Corporation.
